Sanofi successfully prices taps on outstanding bond issues for EUR 500 million
Paris – France – April 6, 2020 – Sanofi (EURONEXT: SAN and NASDAQ: SNY) announces that it has successfully priced tap offerings of EUR 500 million of notes (the “Notes”) on two outstanding tranches:
- €250 million fixed rate notes, increasing the total principal amount of the tranche due April 2025 bearing interest at an annual rate of 1.000% to €1 billion
- €250 million fixed rate notes, increasing the total principal amount of the tranche due April 2030 bearing interest at an annual rate of 1.500% to €1 billion
The Notes are being issued off the company's Euro Medium Term Note Programme.
The transactions enable the company to lower its average cost of debt and extend the average maturity of its debt.
Sanofi intends to use the net proceeds of the offerings for general corporate purposes.
Crédit Agricole CIB, HSBC, Bank of America Securities and Société Générale acted as Global Coordinators and Bookrunners for the offering